Evidence map›Paper›PMID 41050627›Full record

ReviewThe Lancet regional health. Western Pacific2025

Communicable diseases genomics network: promoting and harmonising pathogen genomics implementation for public health in Australia.

Chantel Lin, Amy V Jennison, Lex E X Leong, David J Speers, Ella M Meumann, Louise Cooley, Karina Kennedy, Alicia Arnott, David Winter, William Rawlinson and 10 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Chantel LinCommunicable Diseases Genomics Network, Australia.
Amy V JennisonPublic and Environmental Health Reference Laboratories, Pathology Queensland, Queensland Department of Health, Brisbane, QLD, Australia.
Lex E X LeongSA Pathology, Adelaide, SA, Australia.
David J SpeersDepartment of Microbiology, North West Network, PathWest Laboratory Medicine WA, Nedlands, WA, Australia.
Ella M MeumannMicrobiology Department, Territory Pathology, Royal Darwin Hospital, Darwin, NT, Australia.
Louise CooleyRoyal Hobart Hospital, Hobart, TAS, Australia.
Karina KennedyDepartment of Clinical Microbiology and Infectious Diseases, Canberra Hospital, Garran, ACT, Australia.
Alicia ArnottVictorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne Health, Melbourne, VIC, Australia.
David WinterPublic Health and Forensic Science (PHF Science), Kenepuru, Porirua, New Zealand.
William RawlinsonSerology and Virology Division (SAViD) NSW Health Pathology, Randwick, NSW, Australia.
Jennifer RobsonMicrobiology and Molecular Pathology, Sullivan Nicolaides Pathology, Brisbane, QLD, Australia.
Patrick HarrisCentral Microbiology, Pathology Queensland, Royal Brisbane & Women's Hospital, Herston, QLD, Australia.
Angela DonaldCommunicable Diseases Genomics Network, Australia.
Torsten SeemannCentre for Pathogen Genomics, University of Melbourne, Melbourne, VIC, Australia.
Susan A BallardDepartment of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Martyn KirkNational Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT, Australia.
Vitali SintchenkoCentre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Sydney, NSW, Australia.
Deborah A WilliamsonSchool of Medicine, University of St Andrews, Fife, Scotland, KY16 9TF.
Benjamin P HowdenCentre for Pathogen Genomics, University of Melbourne, Melbourne, VIC, Australia.
Communicable Diseases Genomics Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, the utility of pathogen genomics for public health was highlighted by the COVID-19 pandemic. Approaches to enhance coordination and improve implementation of pathogen genomics for public health are needed. The Communicable Diseases Genomics Network (CDGN) was established in 2015 in Australia. The network, embedded at the public health laboratory interface and supported by the Australian Government, has facilitated a coordinated model in Australia for public health pathogen genomics. CDGN activities have facilitated pilot projects to demonstrate use cases, harmonisation of data sharing and governance arrangements, outbreak and pandemic response, translational research, policy development and workforce capacity building. The impact of CDGN has been enabling the significant progress towards public health genomics implementation in Australia, and providing a model that could be applied in other federated settings, aligned with international best practice.

Indexed as

ImplementationNetworkingPathogen genomicsPublic health

Identifiers

PMID41050627
PMCPMC12494853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.